Jussi Mertsola Selected Research

Whooping Cough (Pertussis)

12/2022	Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups.
1/2022	Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
1/2021	Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis.
1/2021	Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.
1/2021	Pertussis in infants in Nordic countries.
1/2021	Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom.
3/2020	Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination.
1/2020	Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations.
2/2019	Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.
1/2018	Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jussi Mertsola Research Topics

Disease

37	Whooping Cough (Pertussis) 12/2022 - 12/2004
8	Infections 01/2021 - 07/2005
7	Diphtheria 10/2016 - 12/2004
7	Tetanus 10/2016 - 12/2004
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 01/2016
4	Otitis Media 01/2020 - 01/2016
3	Osteitis 01/2017 - 05/2015
2	Respiratory Sounds (Crackle) 01/2020 - 01/2016
1	Reinfection 12/2016
1	Asthma (Bronchial Asthma) 12/2016
1	Tuberculosis (Tuberculoses) 05/2015
1	Disease Susceptibility (Diathesis) 07/2011
1	Cicatrix (Scar) 03/2008
1	Pyelonephritis 03/2008
1	Urinary Tract Infections (Urinary Tract Infection) 03/2008
1	Virus Diseases (Viral Diseases) 11/2006
1	Fever (Fevers) 03/2004
1	Pneumonia (Pneumonitis) 03/2004
1	Hypersensitivity (Allergy) 03/2004
1	Pleural Empyema (Pyothorax) 03/2004
1	With Papillary Renal Neoplasia Papillary Thyroid Carcinoma 04/2003

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2022 - 04/2003
10	AntigensIBA 01/2022 - 12/2004
9	AntibodiesIBA 01/2021 - 04/2003
9	Pertussis ToxinIBA 01/2021 - 08/2009
7	Pertussis VaccineIBA 12/2022 - 05/2005
6	Immunoglobulin G (IgG)IBA 01/2021 - 05/2007
5	pertactin FDA Link 01/2021 - 05/2005
5	Acellular VaccinesIBA 01/2021 - 04/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 03/2004
4	Pentetic Acid (DTPA)FDA LinkGeneric 01/2016 - 12/2004
3	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 09/2010
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2008
3	EnzymesIBA 01/2014 - 05/2005
3	ToxoidsIBA 01/2014 - 09/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2017 - 05/2015
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 05/2017 - 01/2014
2	Interleukin-12 (IL 12)IBA 01/2017 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 08/2006 - 08/2005
1	Adenylate Cyclase ToxinIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2021
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	EpitopesIBA 01/2020
1	MacrolidesIBA 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Erythromycin (Erycette)FDA LinkGeneric 01/2018
1	Interleukin-17 (Interleukin 17)IBA 10/2016
1	Interleukin-10 (Interleukin 10)IBA 10/2016
1	CytokinesIBA 01/2016
1	InterleukinsIBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Toll-Like Receptor 2IBA 05/2015
1	Toll-Like Receptor 4IBA 04/2012
1	Complement System Proteins (Complement)IBA 01/2011
1	Complement C4b-Binding ProteinIBA 01/2011
1	pertussis toxoidIBA 09/2010
1	OligonucleotidesIBA 09/2007
1	BoostrixIBA 05/2007
1	C-Reactive ProteinIBA 11/2006
1	Peptides (Polypeptides)IBA 05/2005
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 03/2004

Therapy/Procedure

2	Ambulatory Care (Outpatient Care) 01/2020 - 01/2016
1	Operative Surgical Procedures 12/2016
1	Length of Stay 03/2004
1	Medical Day Care (Partial Hospitalization) 03/2004
1	Therapeutics 03/2004